Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the quantitative expression of multiple markers on single cells. This data contains invaluable biomedical information on (1) the marker expressions per cell, (2) the variation in such expression across cells, (3) the variability of cell marker expression across samples that (4) may vary systematically between cells collected from donors and patients. Current conventional and even advanced data analysis methods for MFC data explore only a subset of these levels. The Discriminant Analysis of MultiAspect CYtometry (DAMACY) we present here provides a comprehensive view on health and disease responses by integrating all four levels. We validate DAMACY by using three di...
New cytometric techniques continue to push the boundaries of multi-parameter quantitative data acqui...
The balance of inflammation and immunosuppression driven by changed ratios in diverse myeloid and T ...
The development of flow cytometric biomarkers in human studies and clinical trials has been slowed b...
Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the quantitative expre...
Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the quantitative expre...
Multicolour flow cytometry (MFC) is used to measure multiple cellular markers at the single-cell lev...
Flow cytometry is extensively used for the immune-profiling of leukocytes in tissue during homeostas...
Multicolor Flow Cytometry (MFC)-based gating allows the selection of cellular (pheno)types based on ...
This thesis consists of two distinct parts. Firstly, we used flow cytometry and developed new method...
Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone marrow (BM) in...
Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone marrow (BM) in...
AbstractObjectiveFlow cytometry is becoming an important tool in the characterization of different h...
Flow Cytometry (FCM) is widely used to investigate and diagnose human disease. Although high-through...
International audienceBACKGROUND: The development of multiparameter flow cytometry (FCM) and increas...
The development of flow cytometric biomarkers in human studies and clinical trials has been slowed b...
New cytometric techniques continue to push the boundaries of multi-parameter quantitative data acqui...
The balance of inflammation and immunosuppression driven by changed ratios in diverse myeloid and T ...
The development of flow cytometric biomarkers in human studies and clinical trials has been slowed b...
Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the quantitative expre...
Multicolour Flow Cytometry (MFC) produces multidimensional analytical data on the quantitative expre...
Multicolour flow cytometry (MFC) is used to measure multiple cellular markers at the single-cell lev...
Flow cytometry is extensively used for the immune-profiling of leukocytes in tissue during homeostas...
Multicolor Flow Cytometry (MFC)-based gating allows the selection of cellular (pheno)types based on ...
This thesis consists of two distinct parts. Firstly, we used flow cytometry and developed new method...
Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone marrow (BM) in...
Multiparameter flow cytometry (MFC) is one of the essential ancillary methods in bone marrow (BM) in...
AbstractObjectiveFlow cytometry is becoming an important tool in the characterization of different h...
Flow Cytometry (FCM) is widely used to investigate and diagnose human disease. Although high-through...
International audienceBACKGROUND: The development of multiparameter flow cytometry (FCM) and increas...
The development of flow cytometric biomarkers in human studies and clinical trials has been slowed b...
New cytometric techniques continue to push the boundaries of multi-parameter quantitative data acqui...
The balance of inflammation and immunosuppression driven by changed ratios in diverse myeloid and T ...
The development of flow cytometric biomarkers in human studies and clinical trials has been slowed b...